Cardiff Oncology CRDF
NASDAQ CRDF
$0.93 -0.01 (-1.06%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cardiff Oncology (CRDF) Restructuring Costs (2016 - 2018)

Updated

Cardiff Oncology (CRDF) posted Restructuring Costs of $664,686 for FY2018, down 69.4% from $2.17 million in FY2017.

Analysis

Cardiff Oncology (CRDF) Restructuring Costs (2016 - 2018) Analysis & Trends

  • Business Quant data shows CRDF's Restructuring Costs at $2.17 million in FY2017 (+175.1%) and $790,438 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Cardiff Oncology 63.71 Mn 29.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 421,351.00
Jun 30, 2018 243,335.00
Dec 31, 2017 474,251.00
Sep 30, 2017 -46,472.00
Jun 30, 2017 -3,806.00
Mar 31, 2017 1.72 Mn
Dec 31, 2016 790,438.00
API Access

Cardiff Oncology Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=CRDF&period=max&api_key=YOUR_API_KEY